Covered recipient · General Payments record
GEORGE BENES
General Payments · PY2018–2022
$4,798.01
- Reported across 139 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $151.37 | 8 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $96.81 | 5 |
| Janssen Biotech, Inc. | $21.19 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.29 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (8)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.34 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890592049 | CMS |
| ABBVIE INC. | $20.43 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890592051 | CMS |
| ABBVIE INC. | $22.28 | 04/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890592053 | CMS |
| ABBVIE INC. | $17.82 | 04/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890592055 | CMS |
| ABBVIE INC. | $17.94 | 06/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890592057 | CMS |
| Janssen Biotech, Inc. | $21.19 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 885637849 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.08 | 11/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 959777717 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.29 | 03/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955593123 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.